Anpario (LON:ANP) Releases Earnings Results

Anpario (LON:ANP) posted its earnings results on Wednesday. The company reported GBX 22.45 earnings per share for the quarter, Digital Look Earnings reports. Anpario had a net margin of 14.31% and a return on equity of 16.88%.

Anpario Trading Down 2.8%

Shares of LON ANP traded down GBX 13.50 during trading hours on Thursday, reaching GBX 466.50. The stock had a trading volume of 73,137 shares, compared to its average volume of 45,578. Anpario has a 52-week low of GBX 391.11 and a 52-week high of GBX 580. The firm has a market cap of £75.97 million, a price-to-earnings ratio of 12.30 and a beta of 1.08. The business’s fifty day moving average price is GBX 531.50 and its two-hundred day moving average price is GBX 516.75. The company has a current ratio of 4.50, a quick ratio of 5.16 and a debt-to-equity ratio of 0.60.

Wall Street Analysts Forecast Growth

A number of brokerages have commented on ANP. Shore Capital Group reissued a “house stock” rating on shares of Anpario in a research note on Monday, August 17th. Canaccord Genuity Group reaffirmed a “buy” rating and issued a GBX 570 price target on shares of Anpario in a report on Friday, June 26th. One analyst has rated the stock with a Buy rating, According to data from MarketBeat.com, the stock currently has an average rating of “Buy” and a consensus target price of GBX 570.

Anpario Company Profile

Anpario plc, together with its subsidiaries, engages in the production and distribution of natural feed additives for animal health, hygiene, and nutrition. Its health and performance category offers various products that support and maintain animal gut health, such as phytogenic and acid based eubiotics, and omega fatty acids under the Orego-Stim, Optomega, pHorce, Salkil, and Genex brands; feed quality category provides products, such as enzymes, antioxidants, pellet binders, mould inhibitors, and acid based eubiotics under the pHorce, Feedzyme, Salgard, Oxigard, Moldgard, and Mastercube brands.